Latest Breaking News On - Rsys group - Page 3 : vimarsana.com

Shareholders of YS Biopharma Announce an Extraordinary General Meeting

Shareholders of YS Biopharma Announce an Extraordinary General Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesAmerican universityDistrict of columbiaCayman islandsGrand caymanUniversity of massachusettsHong kongEnan zhangYi zhangYisheng xingyeRajit shettyRachel yuJames changViren mehtaAndrew ledbetter

YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024

YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesBrenda wuDavid shaoRobin yangSecurities exchangeDevelopment expensesRsys groupPrnewswire ys biopharma co ltdSource ys biopharma co ltdChinese centerExchange rate informationPeople bankTrademark officeAnnounces unaudited financial resultsFirst halfFiscal year

YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024

YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesBrenda wuRobin yangDavid shaoChinese centerPeople bankRsys groupDevelopment expensesSource ys biopharma co ltdSecurities exchangeTrademark officePrnewswire ys biopharma co ltdExchange rate informationDisease controlUnited states patentInvestigational new drug

YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024

/PRNewswire/ YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma") along with its subsidiaries ("YS Group" or the "Company"), a global biopharmaceutical.

United statesRobin yangBrenda wuDavid shaoChinese centerPeople bankTrademark officePrnewswire ys biopharma co ltdSecurities exchangeDevelopment expensesExchange rate informationSource ys biopharma co ltdRsys groupDisease controlUnited states patentInvestigational new drug

YS Biopharma Announces Unaudited Financial Results for the First Half of Fiscal Year 2024

GAITHERSBURG, Md., Jan. 23, 2024 /PRNewswire/ YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma") along with its subsidiaries ("YS Group" or the

United statesRobin yangBrenda wuDavid shaoExchange rate informationChinese centerPeople bankDevelopment expensesSecurities exchangeTrademark officeRsys groupYs biopharma co ltdDisease controlUnited states patentInvestigational new drugFiscal year